Saniona
15.83 SEK
+1.87 %
Less than 1K followers
SANION
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Saniona
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 2.7 | 8.2 | 10.5 | 15.3 | 16.8 | 334.7 | 434.4 |
| growth-% | 208.4 % | 27.8 % | 45.8 % | 10.2 % | 1,887.4 % | 29.8 % | |
| EBITDA | -101.7 | -156.0 | -402.9 | -217.9 | -71.4 | 249.6 | 277.8 |
| EBIT | -103.9 | -159.4 | -411.6 | -225.7 | -81.1 | 241.9 | 271.0 |
| Profit before taxes | -83.5 | -81.2 | -418.4 | -252.0 | -104.3 | 207.0 | 306.0 |
| Net income | -75.8 | -73.4 | -410.9 | -245.4 | -95.8 | 188.7 | 284.7 |
| EPS | -2.50 | -1.52 | -5.57 | -3.33 | -1.26 | 1.77 | 2.21 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | 0.0 % | 0.0 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -3,826.3 % | -1,902.5 % | -3,845.2 % | -1,426.0 % | -424.1 % | 74.6 % | 63.9 % |
| EBIT-% | -3,909.2 % | -1,944.1 % | -3,927.9 % | -1,477.2 % | -481.4 % | 72.3 % | 62.4 % |
| ROE | -129.7 % | -12.2 % | -145.7 % | -465.5 % | 436.7 % | 81.4 % | 44.8 % |
| ROI | -78.9 % | -10.5 % | -93.3 % | -159.6 % | -151.7 % | 55.5 % | 41.9 % |